Yuwen Zhou

2.0k total citations
53 papers, 868 citations indexed

About

Yuwen Zhou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yuwen Zhou has authored 53 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 15 papers in Surgery. Recurrent topics in Yuwen Zhou's work include Colorectal Cancer Treatments and Studies (16 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Gastric Cancer Management and Outcomes (8 papers). Yuwen Zhou is often cited by papers focused on Colorectal Cancer Treatments and Studies (16 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Gastric Cancer Management and Outcomes (8 papers). Yuwen Zhou collaborates with scholars based in China, United States and Greece. Yuwen Zhou's co-authors include Xuelei Ma, Jiyan Liu, Liansha Tang, Yajuan Zhu, Dan Pu, Wenbo He, Ruolan Xia, Liyuan Yin, Meng Qiu and Qinghua Zhou and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Yuwen Zhou

51 papers receiving 861 citations

Peers

Yuwen Zhou
Christos Fountzilas United States
Yongqiang Li China
Jianwei Zhang China
Xuemin Chen China
Andrea Beer Austria
Akihiro Seki Japan
Yuli Wang China
William A. Hammond United States
Christos Fountzilas United States
Yuwen Zhou
Citations per year, relative to Yuwen Zhou Yuwen Zhou (= 1×) peers Christos Fountzilas

Countries citing papers authored by Yuwen Zhou

Since Specialization
Citations

This map shows the geographic impact of Yuwen Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuwen Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuwen Zhou more than expected).

Fields of papers citing papers by Yuwen Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuwen Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuwen Zhou. The network helps show where Yuwen Zhou may publish in the future.

Co-authorship network of co-authors of Yuwen Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yuwen Zhou. A scholar is included among the top collaborators of Yuwen Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuwen Zhou. Yuwen Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Yuwen, et al.. (2024). N-glycan biosignatures as a potential diagnostic biomarker for early-stage pancreatic cancer. World Journal of Gastrointestinal Oncology. 16(3). 659–669. 3 indexed citations
3.
4.
Zhang, Xingchen, et al.. (2024). Locoregional therapies combined with immune checkpoint inhibitors for liver metastases. Cancer Cell International. 24(1). 302–302. 3 indexed citations
5.
Zhou, Yuwen, et al.. (2023). Perioperative immune checkpoint inhibition for colorectal cancer: recent advances and future directions. Frontiers in Immunology. 14. 4 indexed citations
6.
Xiu, Weigang, Yuwen Zhou, He Du, et al.. (2023). A nomogram for the prediction of the survival of patients with advanced non‐small cell lung cancer and interstitial lung disease. Cancer Medicine. 12(10). 11375–11384. 3 indexed citations
7.
8.
Tang, Liansha, Yuwen Zhou, Jialing Wang, et al.. (2023). Epidemiology, site-specific characteristics and survival of carcinosarcoma: a retrospective study based on SEER database. BMJ Open. 13(12). e077974–e077974. 5 indexed citations
9.
10.
Pu, Dan, Xiaoqian Zhai, Yuwen Zhou, et al.. (2022). A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS?. Annals of Translational Medicine. 10(16). 908–908. 6 indexed citations
11.
Zhou, Yuwen, et al.. (2021). Gallbladder carcinosarcoma: current perspectives and new development. Expert Review of Gastroenterology & Hepatology. 15(10). 1107–1114. 7 indexed citations
12.
13.
Zhang, Qin, Liansha Tang, Yuwen Zhou, Wenbo He, & Weimin Li. (2021). Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management. Frontiers in Immunology. 12. 663986–663986. 74 indexed citations
14.
Pu, Dan, Liyuan Yin, Yuwen Zhou, et al.. (2021). Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer. Frontiers in Oncology. 11. 637504–637504. 69 indexed citations
15.
Xia, Ruolan, et al.. (2021). Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments. Frontiers in Oncology. 11. 633916–633916. 42 indexed citations
16.
Zhou, Yuwen, Yao Xie, Liansha Tang, et al.. (2021). Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduction and Targeted Therapy. 6(1). 317–317. 81 indexed citations
17.
Zhu, Yajuan, Ye Chen, Haoyue Hu, et al.. (2020). Predictive Risk Factors and Online Nomograms for Synchronous Colon Cancer With Liver Metastasis. Frontiers in Oncology. 10. 1681–1681. 9 indexed citations
18.
Zhou, Yuwen, Ruolan Xia, Dan Pu, et al.. (2020). Thyroid function abnormality induced by PD-1 inhibitors have a positive impact on survival in patients with non-small cell lung cancer. International Immunopharmacology. 91. 107296–107296. 30 indexed citations
19.
Zhu, Yueting, Xin‐Zu Chen, Ye Chen, et al.. (2020). Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer. Frontiers in Oncology. 10. 570268–570268. 3 indexed citations
20.
Li, Yanqiu, Jing Zhang, Lingyun Zhang, et al.. (2013). Silencing endothelin-3 expression attenuates the malignant behaviors of human melanoma cells by regulating SPARC levels. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(4). 581–586. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christos Fountzilas Breakdown of academic impact, for papers by Yongqiang Li Breakdown of academic impact, for papers by Jianwei Zhang Breakdown of academic impact, for papers by Xuemin Chen Breakdown of academic impact, for papers by Andrea Beer Breakdown of academic impact, for papers by Akihiro Seki Breakdown of academic impact, for papers by Yuli Wang Breakdown of academic impact, for papers by William A. Hammond
Rankless by CCL
2026